Loading...
0REZ logo

AddLife AB (publ)LSE:0REZ Stock Report

Market Cap SEK 20.3b
Share Price
n/a
1Y-9.2%
7D2.4%
1D0.7%
Portfolio Value
View

AddLife AB (publ)

LSE:0REZ Stock Report

Market Cap: SEK 20.3b

AddLife (0REZ) Stock Overview

Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. More details

0REZ fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance3/6
Financial Health4/6
Dividends0/6

0REZ Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW501,009 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
AG
Agricola
501,009 investors already sharing narratives

AddLife AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for AddLife
Historical stock prices
Current Share PriceSEK 167.34
52 Week HighSEK 207.60
52 Week LowSEK 133.00
Beta1.57
1 Month Change7.27%
3 Month Change12.77%
1 Year Change-9.16%
3 Year Change45.29%
5 Year Change-46.54%
Change since IPO498.22%

Recent News & Updates

Recent updates

Shareholder Returns

0REZGB Life SciencesGB Market
7D2.4%2.5%1.7%
1Y-9.2%-10.2%19.6%

Return vs Industry: 0REZ exceeded the UK Life Sciences industry which returned -10.2% over the past year.

Return vs Market: 0REZ underperformed the UK Market which returned 19.6% over the past year.

Price Volatility

Is 0REZ's price volatile compared to industry and market?
0REZ volatility
0REZ Average Weekly Movement5.3%
Life Sciences Industry Average Movement8.2%
Market Average Movement5.3%
10% most volatile stocks in GB Market10.7%
10% least volatile stocks in GB Market2.9%

Stable Share Price: 0REZ has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: 0REZ's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19062,295Fredrik Dalborgwww.add.life

AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis.

AddLife AB (publ) Fundamentals Summary

How do AddLife's earnings and revenue compare to its market cap?
0REZ fundamental statistics
Market capSEK 20.30b
Earnings (TTM)SEK 568.00m
Revenue (TTM)SEK 10.39b
35.7x
P/E Ratio
2.0x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0REZ income statement (TTM)
RevenueSEK 10.39b
Cost of RevenueSEK 6.41b
Gross ProfitSEK 3.98b
Other ExpensesSEK 3.41b
EarningsSEK 568.00m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

Jul 16, 2026

Earnings per share (EPS)4.66
Gross Margin38.29%
Net Profit Margin5.47%
Debt/Equity Ratio76.0%

How did 0REZ perform over the long term?

See historical performance and comparison

Dividends

0.9%
Current Dividend Yield
32%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 03:43
End of Day Share Price 2026/07/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AddLife AB (publ) is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Karl NorénDanske Bank
Robert RedinDNB Carnegie
Gustav BernebladNordea Markets